OTCMKTS:CGNH CardioGenics (CGNH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About CardioGenics Stock (OTCMKTS:CGNH) Get CardioGenics alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview CardioGenics Holdings, Inc. (OTCMKTS: CGNH) is a clinical diagnostics company specializing in the development, production and commercialization of immunoenzymatic assay kits and instruments for the detection and monitoring of cardiovascular disease. The company’s core focus lies in high-sensitivity cardiac biomarkers, which support early diagnosis of myocardial infarction, heart failure and related conditions. CardioGenics leverages proprietary antibody technology and assay platforms to deliver quantitative test results in clinical laboratory settings. Headquartered in the United States, CardioGenics serves healthcare providers and diagnostic laboratories globally through a combination of direct sales channels and distribution partners. Its product portfolio includes high-sensitivity troponin assays, D-dimer tests and additional biomarker panels, all of which have received regulatory approvals in multiple markets. The company continues to advance its pipeline with new assays targeting emerging cardiovascular risk factors and therapeutic monitoring applications. Since its founding in the early 2000s, CardioGenics has pursued strategic collaborations and licensing agreements to strengthen its technology platform and extend its geographic reach. The management team brings together expertise in molecular diagnostics, clinical chemistry and regulatory affairs, guiding efforts to optimize manufacturing processes and support clinical adoption of the company’s assays worldwide.AI Generated. May Contain Errors. Read More Receive CGNH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CardioGenics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CGNH Stock News HeadlinesCardioGenics (OTCMKTS:CGNH) vs. AngioDynamics (NASDAQ:ANGO) Head to Head ContrastSeptember 10, 2025 | americanbankingnews.comCardioGenics (OTCMKTS:CGNH) Share Price Crosses Above Two Hundred Day Moving Average - Here's WhySeptember 6, 2025 | americanbankingnews.comREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.September 17 at 2:00 AM | Paradigm Press (Ad)CGNH CardioGenics Holdings IncAugust 28, 2024 | seekingalpha.comMagnetic Beads Market Size to Reach USD 6.7 Bn by 2032 with CAGR of 15.5% | TMR StudyApril 6, 2023 | benzinga.comMagnetic Beads Market Size, Share, Growth Statistics, Leading Players and Forecast 2028April 6, 2023 | marketwatch.com2023-2029 Global Cardiac Marker POC Analyzer Market Growth Analysis ReportMarch 29, 2023 | marketwatch.comThe Worldwide Cardiac Biomarkers Industry is Expected to Reach $23.8 Billion by 2027March 10, 2023 | finance.yahoo.comSee More Headlines CGNH Stock Analysis - Frequently Asked Questions How do I buy shares of CardioGenics? Shares of CGNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CardioGenics own? Based on aggregate information from My MarketBeat watchlists, some other companies that CardioGenics investors own include Trinity Biotech (TRIB), Samsung Electronics (SSNLF), Rock Creek Pharmaceuticals (RCPIQ), Merck & Co., Inc. (MRK), MediPharm Labs (MEDIF) and Labrador Iron Mines (LBRMF). Company Calendar Today9/17/2025Fiscal Year End10/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryBusiness Services Current SymbolOTCMKTS:CGNH CIK1089029 Webwww.cardiogenics.com Phone(905) 673-8501Fax905-673-9865Employees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta2.45 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (OTCMKTS:CGNH) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CardioGenics Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CardioGenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.